INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED FILES APPLICATION FOR "ANTI-IL-5 ANTIBODY IN THE TREATMENT OF ASTHMA"

GENEVA, Nov. 24 -- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GSK Medicines Research Centre Gunnels Wood RoadStevenage SG1 2NY) filed a patent application (PCT/EP2025/063309) for "ANTI-IL-5 ANTIBODY IN THE TREATMENT OF ASTHMA" on May 15, 2025. With publication no. WO/2025/238121, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FOLLOWS, Richard Marcus Adam (GSKLegal & Compliance - Global Patents79 New Oxford StLondon WC1A 1DG), BIRD, Nicholas Paul (GSK Medicines Research CentreGunnels Wood RoadStevenage SG1...